Pancreatic tumours are surrounded by a dense layer of connective tissue called the stroma. This barrier limits how much chemotherapy reaches the cancer cells inside the tumour.
Gemcitabine Plus Nab-Paclitaxel — for Pancreatic Cancer
Gemcitabine plus nab-paclitaxel is a two-drug chemotherapy regimen given by intravenous drip for metastatic pancreatic cancer. This page explains what each drug is, how the combination works, and how it compares with the other main regimen, FOLFIRINOX.
- Two drugs combined — Gemcitabine is the backbone. Nab-paclitaxel is a modified form of paclitaxel designed to reach tumour tissue more effectively.
- Given by drip, day care — Both drugs are given intravenously on scheduled treatment days. Overnight hospital admission is not usually required.
- Not the same as regular paclitaxel — Nab-paclitaxel is a distinct formulation — not interchangeable with conventional paclitaxel.
- FOLFIRINOX is the other main option — Both regimens are used for metastatic pancreatic cancer. Which is chosen depends on your fitness and your oncologist's recommendation for your specific situation.
Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed September 2026
Gemcitabine and nab-paclitaxel is a two-drug intravenous chemotherapy regimen used for metastatic pancreatic cancer. Gemcitabine is an antimetabolite that has been used in pancreatic cancer treatment for decades. Nab-paclitaxel is paclitaxel bound to albumin nanoparticles, which changes how the drug moves through the body and reaches tumour tissue.
What are gemcitabine and nab-paclitaxel?
Gemcitabine is an antimetabolite — a chemotherapy drug that interferes with how cancer cells copy their DNA. It has been a standard part of pancreatic cancer treatment for many years and remains the backbone of this regimen.
Nab-paclitaxel (nanoparticle albumin-bound paclitaxel, brand name Abraxane) is a formulation of paclitaxel in which the drug is attached to albumin — a protein naturally present in the blood. This changes how the drug travels through the body and how it is taken up by cells. It is not the same as conventional paclitaxel and cannot be substituted for it.
The two drugs are given together on scheduled treatment days by intravenous drip, over a period of hours. Together they act on pancreatic cancer cells through two different mechanisms.
How does this regimen compare with FOLFIRINOX?
FOLFIRINOX is the other main chemotherapy regimen used in metastatic pancreatic cancer. It contains four drugs: oxaliplatin, irinotecan, fluorouracil, and leucovorin. It is generally considered more intensive than gemcitabine plus nab-paclitaxel.
Because of its intensity, FOLFIRINOX is typically reserved for patients with a strong performance status — those who are well enough to tolerate four drugs and a more demanding infusion schedule. Gemcitabine plus nab-paclitaxel is used in patients who may not tolerate that level of intensity, including those with a somewhat reduced performance status.
Neither regimen is universally preferable to the other. The choice depends on your fitness, organ function, and what your oncologist judges to be the most appropriate plan for your situation. This is a decision made in clinic, not online.
Who is this regimen not suitable for?
Gemcitabine plus nab-paclitaxel is not used in all patients with pancreatic cancer. Eligibility in each case is decided by an oncologist based on a full clinical review, not by a general rule.
- Very poor performance status: patients who have largely lost independent daily function are generally not candidates for combination chemotherapy of this intensity.
- Significant liver or kidney impairment: both drugs are processed in ways that become hazardous when organ function is severely reduced.
- Known severe hypersensitivity to albumin-bound paclitaxel or gemcitabine.
- Pregnancy: both agents are harmful to a developing foetus. Pregnancy must be excluded before treatment begins.
- Resectable disease: when surgery is possible, the treatment pathway is different and this regimen may not apply at this stage.
Your oncologist will assess your blood tests, organ function, fitness score, and the exact stage of your disease before deciding whether this regimen is appropriate for you.
What happens during treatment with this regimen?
Pre-treatment blood tests
Before each cycle, your care team checks your blood counts, kidney function and liver function. These results confirm whether it is safe to proceed.
Oncologist review
Your oncologist reviews your results and confirms the plan for that cycle. Any symptoms or concerns you have should be raised before the drip begins.
Intravenous infusion
Nab-paclitaxel is given first, followed by gemcitabine, both by drip over a period of hours. You remain in the day-care unit throughout. Overnight admission is not usually required.
Monitoring during infusion
A nurse checks your blood pressure, temperature and symptoms during the infusion. Tell your nurse immediately if you feel chest tightness, breathlessness or flushing.
Rest and review between cycles
Rest days are built into every cycle to allow your body to recover. Before the next treatment day, your team reviews your counts and how you have been feeling. Timing may be adjusted based on that review.
Did you know?
Nab-paclitaxel is designed to exploit albumin transport pathways that are more active in tumour tissue — a different delivery mechanism from conventional paclitaxel, which requires chemical solvents that carry their own risk of allergic reaction.
Source: NCCN Clinical Practice Guidelines in Oncology — Pancreatic Adenocarcinoma
What else should I know about this regimen?
What side effects does this regimen cause?
Fatigue is the most commonly reported side effect. Both drugs suppress the bone marrow, which is why blood counts are checked before every treatment day — low counts can mean a delayed cycle, a decision your oncologist makes. Nab-paclitaxel commonly causes peripheral neuropathy: tingling, numbness or pain in the hands and feet. This can persist after treatment ends and is monitored carefully because it affects decisions about continuing. Other common effects include hair thinning or loss, nausea, reduced appetite and diarrhoea. Tell your team about any new or worsening symptom rather than waiting for your next scheduled appointment.
How much does this regimen cost in India?
Cost varies considerably by hospital, by city, and by whether branded or generic formulations are used. Nab-paclitaxel is the more expensive component and is the main driver of this regimen's cost, which is higher than single-agent gemcitabine alone. Any figure quoted online becomes dated quickly. Ask the treating hospital for an itemised written estimate for your specific plan; the number of treatment days and total cycle count both affect the final total. A hospital financial counsellor can advise on whether any government or institutional assistance scheme applies to your situation. These figures are indicative as of the time of writing and may have changed.
Can this regimen be used for locally advanced pancreatic cancer?
Gemcitabine plus nab-paclitaxel has been studied and is most widely established in metastatic pancreatic cancer. In some cases of locally advanced disease it is considered, particularly when the tumour is not surgically removable. Whether it applies depends on the extent of involvement, the proximity to major blood vessels, and whether reducing the tumour to allow surgery is part of the treatment goal. This requires detailed review of your imaging and staging, and is best discussed directly with your treating oncologist rather than assumed from general information.
Will I lose my hair?
Hair thinning or complete hair loss is common with nab-paclitaxel and is one of the effects patients ask about most. In most cases, hair regrows after treatment ends, though the timing and texture can vary between individuals. Scalp cooling during infusion reduces the degree of hair loss in some patients but does not prevent it entirely and is not appropriate in all situations. Ask your nurse whether scalp cooling is available in your unit and whether it is suitable for you.
How many cycles of treatment are given?
The number of cycles is not fixed in advance and is not the same for every patient. Treatment is reviewed regularly — typically after a planned number of cycles — using scans and blood tests to assess how the disease is responding and how well you are tolerating the regimen. The plan may continue, be modified, or stop depending on what those reviews show. Your oncologist will give you an initial plan and explain how the decision to continue or stop will be made.
Can I take Ayurvedic or herbal medicines alongside this chemotherapy?
Tell your oncologist about everything you are taking — prescription medicines, over-the-counter drugs, vitamins, Ayurvedic preparations and herbal products. Some supplements and herbal medicines interact with chemotherapy drugs in ways that change how effective or how toxic the treatment is. This is not a theoretical concern; interactions have been documented in clinical literature. Your oncologist will not dismiss the question. You should not feel you need to hide what you are taking. Disclose everything before treatment begins, and update your team if anything changes during treatment.
Explore 82 more How Chemotherapy Is Given: Regimens, Cycles & Infusion Days topics
Chemotherapy Regimens by Name
- 7+3 and Induction Regimens for Acute Leukaemia
- ABVD Regimen for Hodgkin Lymphoma
- AC and EC Regimens
- AC-T Regimen for Breast Cancer
- BEP Regimen for Testicular and Germ Cell Cancer
- CAPOX and XELOX Regimens
- CHOP Without Rituximab
- Carboplatin-Paclitaxel Regimen
- Cervical Cancer Chemotherapy and Chemoradiation Regimens
- Chemotherapy Regimens: What the Acronyms Mean
- Cisplatin-Pemetrexed and Platinum-Pemetrexed
- Comparing Two Regimens: How the Choice Is Made
- DCF and FLOT Regimens for Stomach Cancer
- Doxorubicin-Ifosfamide and Sarcoma Regimens
- EP and Carboplatin-Etoposide for Small Cell Lung Cancer
- FEC and CMF Regimens
- FOLFIRI Regimen
- FOLFIRINOX and Modified FOLFIRINOX
- FOLFOX Regimen for Colorectal Cancer
- GemCis and MVAC for Bladder Cancer
- Gemcitabine-Nab-Paclitaxel for Pancreatic Cancer
- R-CHOP Regimen for Lymphoma
- Salvage Lymphoma Regimens: ICE, DHAP and ESHAP
- TC Regimen (Docetaxel and Cyclophosphamide)
- TPF and Cisplatin Regimens for Head and Neck Cancer
- VRd, VCd and Myeloma Regimens
- Weekly Cisplatin With Radiation (Chemoradiation)
- Which Regimen Is Used for Which Cancer?
Cycle Delays, Dose Reductions & Changes
- Does a Delay Mean the Cancer Is Growing?
- Does a Reduced Dose Still Work?
- Growth Factor Support to Keep the Schedule
- How Many Delays Are Too Many?
- Infection Delaying a Cycle
- My Counts Were Too Low and the Cycle Was Postponed
- Organ Function Problems Delaying a Cycle
- Stopping Early: What Happens If You Do Not Complete the Course?
- Transfusion During Chemotherapy
- What If I Cannot Tolerate the Treatment?
- What Is a Dose Reduction and Why Was Mine Reduced?
- What to Ask If Your Plan Changes
- Why Chemotherapy Gets Delayed or Reduced
- Why Was My Regimen Switched?
HUB — Chemotherapy Regimens
HUB — Cycles, Schedules and What Happens on Infusion Day
How Chemotherapy Is Given
- Can Chemotherapy Be Given at Home?
- Can Chemotherapy Be Given at a Local Hospital?
- Continuous Infusion Chemotherapy and Portable Pumps
- Day Care vs Admission for Chemotherapy
- How Is Chemotherapy Given? All the Routes Explained
- How Long Does Each Chemotherapy Session Take?
- Intra-Arterial and Regional Chemotherapy
- Intraperitoneal Chemotherapy
- Intrathecal Chemotherapy: Into the Spinal Fluid
- Intravenous Chemotherapy: What the Drip Involves
- Intravesical Chemotherapy for the Bladder
- Is Oral Chemotherapy Weaker Than Injections?
- Oral Chemotherapy: Tablets Instead of a Drip
- Subcutaneous and Intramuscular Chemotherapy
- Topical Chemotherapy Creams
- What Safety Checks Happen Before Each Dose?
- Who Actually Gives Your Chemotherapy?
- Why Does the Route Sometimes Change During Treatment?
Regimens, Cycles & Schedules
- A Printable Chemotherapy Cycle Calendar
- Adding or Removing Cycles Mid-Course
- Blood Tests Before Every Cycle: What They Check
- Day 1, Day 8, Day 15: What the Day Numbers Mean
- Does Delaying a Cycle Reduce the Benefit?
- How Many Cycles Before the First Assessment?
- How the Dose Is Calculated for You
- Keeping a Chemotherapy Symptom Diary
- Planning Your Life Around Chemotherapy Cycles
- Rescheduling or Missing a Chemotherapy Appointment
- Weekly, Two-Weekly and Three-Weekly Schedules
- What Happens Between Cycles?
- What Happens at the Last Cycle?
- What Is Dose Intensity?
- What Is a Chemotherapy Cycle?
- What Is the Nadir and Why Does It Matter?
- Which Days of the Cycle Will I Feel Worst?
- Why Was My Cycle Postponed?
The Infusion Day
Your First Cycle
All How Chemotherapy Is Given: Regimens, Cycles & Infusion Days →
Frequently asked questions
What does 'nab' mean in nab-paclitaxel?
Nab stands for nanoparticle albumin-bound. Albumin is a protein naturally present in the blood, and in this formulation paclitaxel is bound to tiny albumin nanoparticles. This changes how the drug moves through the body compared with conventional paclitaxel, which uses chemical solvents. The albumin-bound formulation is also sold under the brand name Abraxane. It is not interchangeable with standard paclitaxel — the administration and side effect profile differ — and your oncologist's prescription will name the formulation specifically.
Is FOLFIRINOX better than gemcitabine plus nab-paclitaxel?
Neither regimen is universally better. They are different tools suited to different patient profiles. FOLFIRINOX contains four drugs and is generally used in patients with strong physical fitness. Gemcitabine plus nab-paclitaxel is used more broadly, including in patients who would not tolerate FOLFIRINOX's intensity. The choice between them is a clinical judgement based on your fitness, organ function, treatment goals, and the specifics of your disease. If both have been mentioned, ask your oncologist to explain the recommendation for your situation and what it is based on.
Is any fever during chemotherapy an emergency?
Any fever that develops during chemotherapy — or in the days after a treatment day — should be treated as a potential emergency. Both gemcitabine and nab-paclitaxel suppress white blood cells, which means your ability to fight infection is reduced. A fever can be the only early warning sign of febrile neutropenia, a serious condition that needs same-day assessment. Do not wait for a scheduled appointment. Call your oncology team or go to an emergency department immediately. Your team will give you a contact number before treatment begins — keep it with you at all times.
How long does a treatment infusion take?
The infusion takes several hours, though the exact duration depends on how the regimen is structured for you and the policies of your treating centre. Nab-paclitaxel is given first, then gemcitabine, each by drip. You sit in the day-care unit throughout. Plan for most of a day on each treatment day — bring something to read or anything else that helps. A family member can usually accompany you, but check with your unit about their visitor policy.
What scans are used to check whether treatment is working?
CT scans are the most commonly used imaging for monitoring response in pancreatic cancer. PET-CT is used in some cases. Your oncologist will order scans at planned intervals — typically after a set number of cycles — to assess whether the tumour is responding, stable or progressing. A blood marker called CA 19-9 is often measured alongside scans in pancreatic cancer, though it is not used alone to make treatment decisions. Your team will explain what your results mean at each review.
Can I take something for nausea before I come in?
Your care team will prescribe anti-nausea medicine to take alongside chemotherapy. Use it as directed — before symptoms appear, not only once they start, as it works better that way. Light meals before the infusion are usually easier to manage than heavy ones. Stay well hydrated on treatment days and in the days following. If nausea is severe despite anti-nausea medicine, tell your nurse or oncologist — it can often be adjusted. Do not use over-the-counter anti-nausea medicine without checking with your team first.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Chemotherapy Topics
Browse our complete chemotherapy guide — 1133 pages on side effects, medicines, cost, daily life and care in Hyderabad. Tap any topic to read more.